labetalol
Ligand Summary
A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
UNII: R5H8897N95
PubChem: 3869
Guide to Pharmacology: 7207
ChEMBL: CHEMBL429
DrugCentral: 1531
LyCHI: 3ZGPVBF8GZQ6
Target Activities
11 Activities
Items per page:
1 – 10 of 11
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Ki | ||||||
Ki | ||||||
Ki | ||||||
Ki | ||||||
IC50 | ||||||
Ki | ||||||
Ki | ||||||
IC50 | ||||||
IC50 | ||||||
Ki | ANTAGONIST | |||||